PT1305082E - Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca - Google Patents

Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca

Info

Publication number
PT1305082E
PT1305082E PT01952773T PT01952773T PT1305082E PT 1305082 E PT1305082 E PT 1305082E PT 01952773 T PT01952773 T PT 01952773T PT 01952773 T PT01952773 T PT 01952773T PT 1305082 E PT1305082 E PT 1305082E
Authority
PT
Portugal
Prior art keywords
pain
phenyl
alkyl
enxaqueca
salvas
Prior art date
Application number
PT01952773T
Other languages
English (en)
Inventor
Richard P Shank
Carlos R Plata-Salaman
Ellen E Codd
Katherine E Rogers
Boyu Zhao
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1305082(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of PT1305082E publication Critical patent/PT1305082E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT01952773T 2000-07-21 2001-07-16 Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca PT1305082E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21965700P 2000-07-21 2000-07-21

Publications (1)

Publication Number Publication Date
PT1305082E true PT1305082E (pt) 2004-09-30

Family

ID=22820176

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01952773T PT1305082E (pt) 2000-07-21 2001-07-16 Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca

Country Status (28)

Country Link
US (4) US20020107283A1 (pt)
EP (1) EP1305082B1 (pt)
JP (1) JP5271473B2 (pt)
KR (1) KR100792814B1 (pt)
CN (1) CN1250213C (pt)
AT (1) ATE267629T1 (pt)
AU (2) AU2001273493B2 (pt)
BG (1) BG107529A (pt)
BR (1) BR0112713A (pt)
CA (1) CA2416819C (pt)
CZ (1) CZ2003445A3 (pt)
DE (1) DE60103546T2 (pt)
DK (1) DK1305082T3 (pt)
EA (1) EA005648B1 (pt)
ES (1) ES2221651T3 (pt)
HU (1) HUP0302940A3 (pt)
IL (2) IL154052A0 (pt)
MX (1) MXPA03000619A (pt)
MY (1) MY127317A (pt)
NO (1) NO330055B1 (pt)
NZ (1) NZ523851A (pt)
PL (1) PL365701A1 (pt)
PT (1) PT1305082E (pt)
SK (1) SK1962003A3 (pt)
TR (1) TR200401511T4 (pt)
UA (1) UA74195C2 (pt)
WO (1) WO2002007822A2 (pt)
ZA (1) ZA200301403B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067922A1 (en) 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in the treatment of pain
CA2454049A1 (en) 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain
CN1592617A (zh) * 2001-07-16 2005-03-09 奥索-麦克尼尔药品公司 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
AU2003293500A1 (en) * 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
EP1850841A1 (en) * 2005-01-20 2007-11-07 Janssen Pharmaceutica N.V. Methods for qt interval control
KR101541383B1 (ko) 2006-03-30 2015-08-03 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
WO2008063284A2 (en) * 2006-10-10 2008-05-29 Janssen Pharmaceutica Nv Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
HU191549B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
KR20010013435A (ko) * 1997-06-05 2001-02-26 고든 라이트 5-나프탈렌-1-일-1,3-디옥산 유도체, 제조 및 치료에의 이용
NZ527991A (en) * 2001-02-27 2005-04-29 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating psychotic disorders
PL364638A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
NZ551954A (en) * 2001-02-27 2008-07-31 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating movement disorders

Also Published As

Publication number Publication date
DE60103546T2 (de) 2005-06-09
CN1458853A (zh) 2003-11-26
BG107529A (bg) 2003-09-30
ATE267629T1 (de) 2004-06-15
PL365701A1 (en) 2005-01-10
UA74195C2 (uk) 2005-11-15
SK1962003A3 (en) 2004-08-03
EP1305082A2 (en) 2003-05-02
IL154052A (en) 2008-07-08
CA2416819C (en) 2011-03-22
JP5271473B2 (ja) 2013-08-21
CA2416819A1 (en) 2002-01-31
NZ523851A (en) 2004-09-24
MY127317A (en) 2006-11-30
KR100792814B1 (ko) 2008-01-14
US20020107283A1 (en) 2002-08-08
EP1305082B1 (en) 2004-05-26
HUP0302940A2 (hu) 2003-12-29
EA200300042A1 (ru) 2003-06-26
EA005648B1 (ru) 2005-04-28
NO330055B1 (no) 2011-02-14
HUP0302940A3 (en) 2012-02-28
TR200401511T4 (tr) 2004-08-23
ES2221651T3 (es) 2005-01-01
MXPA03000619A (es) 2004-07-30
IL154052A0 (en) 2003-07-31
NO20030299D0 (no) 2003-01-20
WO2002007822A3 (en) 2002-05-30
ZA200301403B (en) 2004-06-15
NO20030299L (no) 2003-03-12
US20060183795A1 (en) 2006-08-17
AU2001273493B2 (en) 2005-08-11
DK1305082T3 (da) 2004-09-13
KR20030022300A (ko) 2003-03-15
CZ2003445A3 (cs) 2004-08-18
BR0112713A (pt) 2003-07-22
US20090281179A1 (en) 2009-11-12
DE60103546D1 (de) 2004-07-01
WO2002007822A2 (en) 2002-01-31
JP2004504362A (ja) 2004-02-12
AU7349301A (en) 2002-02-05
CN1250213C (zh) 2006-04-12
US20040266866A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY133370A (en) Carbamate compounds for use in preventing or treating bipolar disorders
PT1408953E (pt) Compostos carbamato para utilizacao na prevencao ou tratamento do disturbio bipolar
PT1305082E (pt) Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
PT1399144E (pt) Compostos carbamato para utilizacao na prevencao ou tratamento de disturbios de ansiedade
NO20040176L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
HK1063288A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain